For example, we observed an increasing trend for HAMP and SAA2 levels towards the end of the treatment period (patient 3) and stable levels (patient 4) (Fig. 3 B).
← all excerpts
Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation.
1
—
—